raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:75373

Progressive bifocal chorioretinal atrophy

Synonyms: CRAPB · PBCRA

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Infancy, Neonatal
Status
active

A rare genetic isolated chorioretinal dystrophy characterized by distinctive slowly progressing chorioretinal atrophic lesions inducing significant visual impairment. There are three clinical stages. Atrophic macular lesion and nasal subretinal deposits are evident soon after birth (stage 1), the macular lesions progress beyond the retinal vascular arcades, and the foci of nasal atrophy coalesce into a confluent white lesion (stage 2), and marked expansion of both the macular and the nasal atrophic lesions toward the optic disc is observed (stage 3). Patients may also present with photophobia, nystagmus and myopia.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enProgressive bifocal chorioretinal atrophyCRAPB · PBCRA
frAtrophie bifocale choriorétinienne progressive
deAtrophie, bifokale chorioretinale progressivePBCRA · Progressive bifokale chorioretinale Atrophie
esAtrofia progresiva bifocal de la coroides y la retinaAtrofia coriorretiniana bifocal progresiva
itAtrofia corioretinica bifocale progressiva
nlProgressieve bifocale chorioretinale atrofie= en
ptAtrofia coriorretiniana bifocal progressivaAtrofia coriorretiniana bifocal progressiva · CRAPB
plPostępujący dwuogniskowy zanik błony naczyniowej i siatkówki= en
csProgresivní bifokální chorioretinální atrofie= en
ukПрогресуюча біфокальна хоріоретинальна атрофія= en
zh进行性双焦点型脉络膜视网膜萎缩= en
trİlerleyici bifokal koryoretinal atrofi= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM600790Evalidated
ICD-10H35.5NTBTattributedvalidated
ICD-119B70NTBTindexvalidated
MONDO0010932Evalidated
MeSHC535356Evalidated
UMLSC1833321Evalidated
GARD10123Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
DHS6S1Disease-causing germline mutation(s) inAssessed6168426q16.2DNase1 hypersensitivity, chromosome 6, site 130710461[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families2 familiesWorldwideFamily(ies)Validated5686965[PMID]_8541856[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_5686965[PMID]_8541856[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

7 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0001135Chorioretinal dystrophy
HP:0000565Esotropia
HP:0007401Macular atrophy
HP:0000545Myopia
HP:0000639Nystagmus
HP:0000505Visual impairment
Occasional (29-5%)
HP:0000580Pigmentary retinopathy

Run the differential on the 6 obligate / very frequent terms

Annotation source: 8541856[PMID]

7

Sources for this card